Latest Specialised Therapeutics Australia Pty Ltd Stories
- ABRAXANE plus gemcitabine to be PBS listed for Australian patients with metastatic pancreatic cancer from 1 November MELBOURNE, Australia, Oct.
-- Intravitreal corticosteroid implant for treatment of vision impairment associated with diabetic macular oedema MELBOURNE, Australia and ATLANTA, April 28, 2014 /PRNewswire/ -- Australian
ATLANTA and MELBOURNE, Australia, April 28, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
-- ABRAXANE plus gemcitabine approved by the TGA for the first-line treatment of metastatic pancreatic cancer MELBOURNE, Australia, March 18, 2014 /PRNewswire/ -- Australian biopharmaceutical
MELBOURNE, Australia, Jan.
- Agreement to Distribute Oncotype DX(R) in Australia and New Zealand MELBOURNE, Australia, Jan.